MRI/TRUS fusion target biopsy against prostate cancer using real-time virtual sonography

MRI/TRUS fusion target biopsy against prostate cancer using real-time virtual sonography - RVS fusion target biopsy against prostate cancer

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000026710

Enrollment

275

Registered

2017-03-27

Start date

2017-03-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer

Interventions

Real-time virtual sonography (target biopsy) systematic biopsy

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1) PSA level (2.5-20ng/ml) 2) Suspicious of localized prostate cancer by digital rectal examination 3) Suspicious of localized prostate cancer by MRI (PI-RADS score >=3) 4) patients who was obtained informed consent

Exclusion criteria

Exclusion criteria: 1) Suspicious of invasive prostate cancer by digital rectal examination 2) Suspicious of invasive prostate cancer by MRI 3) Patients with coagulation disorder 4) Patients who can not be performed TRUS because of anal stenosis

Design outcomes

Primary

Measure	Time frame
Cancer-detected rates of the targeted biopsy compared to systematic biopsy	—

Countries

Japan

Contacts

Public ContactShuzo Hamamoto

Nagoya City University Graduate School of Medical Sciences Nephro-urology

hamamo10@med.nagoya-cu.ac.jp052-853-8266

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026